Canandaigua National Bank & Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Canandaigua National Bank & Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$269K	Buy	2,692 +445	+20%	+$57.5K	0.06%	197
2019 Q4	$335K	Sell	2,247 -22	-1%	-$2.99K	0.06%	207
2019 Q3	$291K	Sell	2,269 -64	-3%	-$8.58K	0.05%	219
2019 Q2	$333K	Buy	2,333 +641	+38%	+$86.1K	0.06%	205
2019 Q1	$242K	Sell	1,692 -154	-8%	-$20.1K	0.05%	240
2018 Q4	$229K	Sell	1,846 -159	-8%	-$23.6K	0.05%	245
2018 Q3	$337K	Sell	2,005 -22	-1%	-$3.78K	0.06%	221
2018 Q2	$349K	Buy	+2,027	New	+$331K	0.07%	218

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Canandaigua National Bank & Trust's JAZZ Position: Q1 2020 in Review

Canandaigua National Bank & Trust increased its Jazz Pharmaceuticals (JAZZ) stake by 20% in Q1 2020, buying an estimated $57.5K and bringing the position to 2,692 shares worth $269K. The position accounts for 0.06% of the portfolio, ranked #197.

Canandaigua National Bank & Trust first reported a position in JAZZ in Q2 2018 and has held it in 8 quarters since. The position peaked at $349K in Q2 2018. 408 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

Canandaigua National Bank & Trust held 2,692 shares of Jazz Pharmaceuticals worth $269K as of Q1 2020.
Canandaigua National Bank & Trust bought 445 Jazz Pharmaceuticals shares in Q1 2020, an estimated $57.5K.
Jazz Pharmaceuticals made up 0.06% of Canandaigua National Bank & Trust's portfolio in Q1 2020, its #197 holding.
Canandaigua National Bank & Trust first reported a position in Jazz Pharmaceuticals in Q2 2018 and has held it in 8 quarters since.
Canandaigua National Bank & Trust's Jazz Pharmaceuticals position peaked at $349K in Q2 2018.
408 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on Canandaigua National Bank & Trust's 13F filing for Q1 2020, filed 16 Apr 2020.